WASHINGTON, Aug. 6 -- Sen. Bill Hagerty issued the following press release: On Wednesday, Senator Bill Hagerty (R-TN), a member of the Senate Banking Committee, introduced the End Housing Welfare for... Read More
WASHINGTON, Aug. 6 -- Sen. Joni Ernst issued the following press release: U.S. Senator Joni Ernst (R-Iowa) and U.S. Senator Chuck Grassley (R-Iowa), along with U.S. Representatives Mariannette Miller... Read More
WASHINGTON, Aug. 6 -- Sen. Joni Ernst issued the following press release: U.S. Senator Joni Ernst (R-Iowa) released the following statement after Senate Agriculture Committee Democrats voted against ... Read More
WASHINGTON, Aug. 6 -- Sen. Tammy Duckworth issued the following press release: U.S. Senator Tammy Duckworth (D-IL) joined U.S. Senators Jeff Merkley (D-OR) and Richard Blumenthal (D-CT) in unveiling ... Read More
WASHINGTON, Aug. 6 -- Sen. Tammy Duckworth issued the following press release: Combat Veteran and U.S. Senator Tammy Duckworth (D-IL) today led 17 of her Senate Democratic colleagues in introducing l... Read More
WASHINGTON, Aug. 6 -- Sen. Tammy Duckworth issued the following press release: U.S. Senator Tammy Duckworth (D-IL) along with U.S. Senate Democratic Whip Dick Durbin (D-IL) and U.S. Representative Ni... Read More
WASHINGTON, Aug. 6 -- Sen. John Curtis issued the following press release: During a Small Business and Entrepreneurship Committee hearing attended by Utah Farm Bureau Federation President ValJay Rigb... Read More
WASHINGTON, Aug. 6 -- Sen. John Curtis issued the following press release: The U.S. Senate passed the Youth Poisoning Prevention Act, bipartisan legislation led by U.S. Senators John Curtis (R-UT), T... Read More
U.S., Aug. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07746947) titled 'PROMISE Registry: PROspective Study on Management of Ischemic Stroke Secondary to mEvo Regis... Read More
U.S., Aug. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07746388) titled 'Adaptive Chemotherapy for Pd-l1 High REsEctablE NSCLC: A Chemo-PHREE Trial' on July 29. Bri... Read More